The dermatomyositis market is expected to witness steady growth over the next decade, driven by increasing awareness, improved diagnostic tools, and advancements in treatment options. The rising ...

Anti-TIF1-γ antibodies are strongly associated with malignancy, with peak risk 3–5 years before and after disease onset. Characteristic cutaneous findings of anti-TIF1-γ positive dermatomyositis, ...

DelveInsight’s “ Dermatomyositis Market Insight, Epidemiology, and Market Forecast – 2034 ” provides an in-depth analysis of the current landscape and future outlook of the DM market across major ...

7. Dermatomyositis Epidemiology and Patient Population 8. Country-Specific Patient Population of Dermatomyositis 9. Dermatomyositis Current Treatment and Medical Practices 10. Dermatomyositis ...

The dermatomyositis market is expected to witness steady growth over the next decade, driven by increasing awareness, improved diagnostic tools, and advancements in treatment options. The rising ...

A woman in her 20s presented with chest pain, dyspnoea, arthralgia, muscle weakness and skin discolouration. She was diagnosed with dermatomyositis. During her admission, she developed pleuritic chest ...

Ovarian cancer coexisting with dermatomyositis is well recognized, [1, 2] and more often than not the latter precedes the malignancy by months to years. [2] ...

A 28-year-old man presented to our rheumatology department with a 10-year history of progressive facial and truncal rash and mild muscle weakness. He had previously presented with these symptoms at a ...

Braz J Med Biol Res, February 2005, Volume 38 (2) 309-313 Bone mineral density of Brazilian girls with juvenile dermatomyositis T.C.M. de Castro 1, M.T.R.A. Terreri 1, V.L. Szejnfeld 2, C. Len 1, ...

Subscribe to Scientific American to learn and share the most exciting discoveries, innovations and ideas shaping our world today. Subscription Plans Give a Gift Subscription ...